ABBOTT LABORATORIES (ABL.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:ABL - US0028241000 - Common Stock
ABL.DE Key Statistics, Chart & Performance
The current stock price of ABL.DE is 91.71 EUR. In the past month the price decreased by -13.82%. In the past year, price decreased by -22.72%.
ABL.DE Technical Analysis
ABL.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE. ABL.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
ABL.DE Financial Highlights
Over the last trailing twelve months ABL.DE reported a non-GAAP Earnings per Share(EPS) of 4.39. The EPS increased by 10.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.88% | ||
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| Debt/Equity | 0.23 |
ABL.DE Forecast & Estimates
35 analysts have analysed ABL.DE and the average price target is 125.19 EUR. This implies a price increase of 36.51% is expected in the next year compared to the current price of 91.71.
For the next year, analysts expect an EPS growth of 11.35% and a revenue growth 7.19% for ABL.DE
ABL.DE Ownership
About ABL.DE
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS US
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / ABL.DE FAQ
What does ABL do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Can you provide the latest stock price for ABBOTT LABORATORIES?
The current stock price of ABL.DE is 91.71 EUR. The price decreased by -3.24% in the last trading session.
Does ABL stock pay dividends?
ABBOTT LABORATORIES (ABL.DE) has a dividend yield of 2.32%. The yearly dividend amount is currently 1.89.
What is the ChartMill rating of ABBOTT LABORATORIES stock?
ABL.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting ABL stock to perform?
35 analysts have analysed ABL.DE and the average price target is 125.19 EUR. This implies a price increase of 36.51% is expected in the next year compared to the current price of 91.71.
What is the expected growth for ABL stock?
The Revenue of ABBOTT LABORATORIES (ABL.DE) is expected to grow by 7.19% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.